Results 141 to 150 of about 2,709,664 (338)
Renal Secondary Hyperparathyroidism in Aged Sprague-Dawley Rats [PDF]
C. Itakura, Masatoshi Iida, M Goto
openalex +1 more source
Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate
ABSTRACT Chronic kidney disease (CKD) affects over 10% of the world's population and is associated with high morbidity and mortality rates. The management of CKD is complex; CKD alters drug pharmacokinetics and pharmacodynamics and further complicates therapeutic strategies regimens.
Sophie Liabeuf+6 more
wiley +1 more source
Epidemiological studies have linked vitamin D deficiency to an increased incidence of myocardial infarction and support a role for vitamin D signalling in the pathophysiology of myocardial infarction.
Kristopher Ford+7 more
doaj +1 more source
Postmenopausal Osteoporosis as a Manifestation of Renal Hypercalciuria with Secondary Hyperparathyroidism* [PDF]
Khashayar Sakhaee+3 more
openalex +1 more source
An Update: Enzymatic Synthesis for Industrial Applications
Biocatalysis has become a sustainable and cost‐competitive alternative to established chemical synthesis, enabling the enzyme‐based production of not only commodity chemicals but (non‐natural) amino acids, (rare) sugars, as well as synthetic nucleotides.
Thomas Bayer+4 more
wiley +1 more source
Semir Abdi Usmael,1 Sisay Molla Ansa,1 Derejie Woldesilasie Tufa2 1Department of Internal Medicine, Haramaya University, College of Health and Medical Science, Harar, Ethiopia; 2Department of Radiology, Haramaya University, College of Health and Medical ...
Usmael SA, Ansa SM, Tufa DW
doaj
Secondary hyperparathyroidism in patient with type 2 diabetes and stages 3–4 chronic kidney disease
Secondary hyperparathyroidism is an early complication of chronic kidney disease, with increasing severity as the glomerular filtration rate decreases and characterized by a progressive increase in parathyroid hormone and growth of the parathyroid glands.
Lilit V. Egshatyan+1 more
doaj +1 more source
Mucolipidosis II presenting as severe neonatal hyperparathyroidism [PDF]
Mucolipidosis II (ML II or I-cell disease ) (OMIM 252500) is an autosomal recessive lysosomal enzyme targeting disorder that usually presents between 6 and 12 months of age with a clinical phenotype resembling Hurler syndrome and a radiological picture ...
Braverman, Nancy+9 more
core
Racial Differences in Secondary Hyperparathyroidism
Dear Editor, I have recently read an interesting paper by Dr. Seck who had examined the prevalence of CKD-MBD in black African (Senegalese) patients on regular hemodialysis (HD) in a cross-sectional fashion (Nephrol-Urol Mon. 2012; 4(4): 613-616) (1).
openaire +4 more sources
Secondary hyperparathyroidism (SHPT) remains a serious complication in patients with chronic kidney disease, and some patients require parathyroidectomy.
Y. Tominaga+5 more
semanticscholar +1 more source